Moneycontrol PRO

API export restriction: Takeaways for Indian pharma industry

March 05, 2020 / 07:39 PM IST
API export restriction: Takeaways for Indian pharma industry

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - 13 APIs & formulations kept under restricted list for exports - Impact would be more in terms of pricing than volumes - Pricing impact likely for Granules India, Aarti drugs, JB Chemicals and Anuh Pharma - Investors should position for companies having a broad portfolio The Directorate General of Foreign Trade has notified that 13 APIs (Active Pharmaceutical Ingredient) and its formulations are now under the restricted list for exports. This isn’t a blanket export ban—what it means is that exporters of these ingredients need...

  • PRO Panorama

    Moneycontrol Pro Panorama | Why is India burning less bright for foreign investors?

    Oct 27, 2021 / 04:57 PM IST

    In today’s edition of Moneycontrol Pro Panorama: China chokes on steel, Kotak Bank’s growth catch-up, what the massive forex kitty says, Start-up Street and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | The Maharaja has left the building

    Oct 9, 2021 / 11:27 AM IST

    Privatisation of Air India means a one-time hit to the exchequer in the form of debt, but it’s a small price to pay for the government

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers